Physician

Michael Krutzik, MD

According to 2025 Medicare claims, Michael Krutzik, MD (NPI: 1447290168) practices pulmonary disease in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is MICHAEL N KRUTZIK MD A MEDICAL CORPORATION (NPI: 1528253572; TIN: 260972612) and primary practice location at 92243-3274.

Krutzik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 751 traditional Medicare patients, billed 4,288 HCPCS/CPT codes, and received $308,437 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,947 prescription claims across 544 beneficiaries totaling $3,364,758 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 1,213 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $430,162 to $308,437. In contrast, Part D prescription costs have moved sharply higher in recent years, from $441,554 to $3,364,758. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $122,763 and ending at $71,085.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	885	5,603	$430,162
2016	1,155	7,559	$542,288
2017	1,109	6,393	$445,774
2018	1,088	6,180	$415,804
2019	1,038	5,522	$373,421
2020	965	4,232	$386,383
2021	811	3,783	$295,977
2022	854	3,729	$285,481
2023	732	4,126	$298,869
2024	751	4,288	$308,437

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	370	3,011	$441,554
2016	552	4,520	$890,900
2017	580	5,413	$1,193,098
2018	601	4,669	$1,560,184
2019	561	4,319	$1,722,792
2020	495	3,718	$1,795,621
2021	473	3,845	$2,062,039
2022	490	4,002	$2,632,343
2023	522	4,085	$3,102,629
2024	544	3,947	$3,364,758

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	265	1,412	$115,416
2016	397	2,372	$141,620
2017	331	2,381	$142,872
2018	273	1,921	$126,219
2019	276	1,832	$189,455
2020	267	1,792	$205,123
2021	239	1,911	$183,322
2022	270	1,766	$163,992
2023	223	1,535	$128,063
2024	197	1,213	$80,455

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	474	971	$102
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	145	145	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	398	651	$76
94060	Test to measure expiratory airflow and volume changes before and after medication administration	107	118	$33
94375	Test to measure rate of airflow	577	1,123	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	177	5,310	$2,166,907
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	502	17,970	$362,252
Pirfenidone	Pirfenidone	33	990	$135,792
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	165	5,520	$107,632
Xolair	Omalizumab	22	616	$71,295

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	76	500	$33,731
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	21	$18,226
E1392	Portable oxygen concentrator, rental	Y	52	360	$12,126
J7682	Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams	N	N/R	15	$11,172
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	24	79	$1,914

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Michael Krutzik, MD?

Tedicare shows public-source Medicare data for Michael Krutzik, MD (NPI 1447290168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Krutzik, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Krutzik, MD?

Michael Krutzik, MD is linked to MICHAEL N KRUTZIK MD A MEDICAL CORPORATION (billing NPI 1528253572) in the available physician profile data.

Does Michael Krutzik, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.